Poor prognosis and risk factors of nonoperative treatment hip fracture patients with end-stage renal disease

Ping-Ying Zhan,Yang-Zhen Lu,Li-Hong Wang

DOI: https://doi.org/10.1097/md.0000000000036446

IF: 1.6

2024-01-20

Medicine

Abstract:Hip fracture is considered to be the most common serious injury in older people. Hip fractures are often meant with high morbidity and mortality. According to the UK National Hip Fracture Database, about 7% of patients with hip fractures die within 1 month. [ 1 ] Over time, the morbidity of hip fractures in the population is still increasing. [ 2 ] In Sadat-Ali M. et al study, [ 3 ] the 1-year mortality rate associated with hip fractures was 26.98%, which is similar to the results of previous studies. [ 4 ] Complications such as pulmonary infection, [ 5 ] pressure ulcers, delirium, urinary tract infection, renal insufficiency, deep vein thrombosis, or pulmonary embolism following hip fractures are common, [ 6 ] and they directly or indirectly endanger the lives of patients. The preferred treatment for hip fractures is surgical treatment, including hip arthroplasty [ 7 ] and internal fixation. [ 8 ] Hip fracture guidelines recommend that patients should undergo surgery treatment as soon as possible, ideally, within 24 or 36 hours. [ 1 ] A new study in Israel suggests that earlier hip fracture surgery is beneficial for older patients, even taking into account their co-morbidities and medication intake. [ 9 ] Though early surgery is the consensus for hip fracture treatment, it is undeniable that it can be affected by many factors, such as diabetes, anticoagulants, pulmonary embolism, perioperative transfusion, [ 10 ] and end-stage renal disease (ESRD). [ 11 ]

medicine, general & internal